Effects of Mirror Therapy on Lower Extremity in CP Children
A non-progressive condition that harms the developing brain both during and after birth is cerebral palsy (CP). It is a multifaceted syndrome marked by abnormalities in movement and posture, along with concomitant sensory-motor, cognitive, and behavioral impairments and seizures. CP can be divided into three types base
| Condition(s) | Cerebral Palsy |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | A non-progressive condition that harms the developing brain both during and after birth is cerebral palsy (CP). It is a multifaceted syndrome marked by abnormalities in movement and posture, along with concomitant sensory-motor, cognitive, and behavioral impairments and seizures. CP can be divided into three types based on neurological classification: spastic, athetoid, and ataxic, impairments in motor skills and posture are hallmarks of cerebral palsy. Various strategies have been employed in motor skill improvement interventions. One of them, mirror-mediated treatment, works by stimulating mirror neurons in a specific region of the brain cortex. Mirror-mediated therapy involves the patient observing movement of his or her own limb reflected in a mirror, which activates mirror neurons. Th |
| Who can participate | Inclusion Criteria: * Age 6-12 years. * Motor tone of effected lower extremity is 1 to 2 according to modified Ashworth scale. * Patient with enough cognition to understand and follow instructions Exclusion Criteria: * Patients with any other neurological illness affecting their lower extremities (e.g., MS, Parkinson's, peripheral neuropathy). * Patients with prior fractures of the lower limb (ankle or foot). * Patients with other forms of musculoskeletal diseases such as severe arthritis, ankle surgery, leg length difference. |
| Ages | 6 Years to 12 Years |
| Sex | All |
| Lead sponsor | Riphah International University |
| Locations | Lahore, Punjab Province, Pakistan |
| Start date | 2024-10-29 |
| NCT ID | NCT06673823 |
| Official listing | https://clinicaltrials.gov/study/NCT06673823 |